We are live on ! Find out more
SCM

Scopia Capital Management Portfolio holdings

AUM $146M
1-Year Est. Return 25.93%
This Fund
S&P 500
This Quarter Est. Return
-19.1%
1 Year Est. Return
+25.93%
3 Year Est. Return
+30.87%
5 Year Est. Return
+45.28%
10 Year Est. Return
+379.83%
AUM
$2.95B
AUM Growth
-$2.25B
Cap. Flow
-$1.42B
Cap. Flow %
-48.07%
Top 10 Hldgs %
68.71%
Holding
40
New
3
Increased
6
Reduced
14
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 30.92%
2 Industrials 20.17%
3 Technology 16.89%
4 Utilities 10.39%
5 Consumer Discretionary 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPR
1
DELISTED
Spirit AeroSystems
SPR
$335M 11.36%
4,645,750
-715,363
-13% -$58M
VST icon
2
Vistra
VST
$48.4B
$306M 10.39%
13,373,518
+1,302,157
+11% +$30.7M
ITRI icon
3
Itron
ITRI
$4.49B
$241M 8.16%
5,086,532
-313,636
-6% -$16.6M
JCI icon
4
Johnson Controls International
JCI
$84.3B
$238M 8.08%
8,034,412
+555,559
+7% +$18.3M
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$210M 7.11%
10,725,642
-4,036,712
-27% -$79.1M
JD icon
6
JD.com
JD
$43.3B
$160M 5.43%
7,651,273
+507,345
+7% +$11.4M
ETRN
7
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$142M 4.81%
+7,086,893
New +$150M
TVTX icon
8
Travere Therapeutics
TVTX
$5.14B
$134M 4.54%
5,910,853
-608,572
-9% -$15.1M
GWPH
9
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$131M 4.44%
1,345,198
-142,109
-10% -$18.6M
NXPI icon
10
NXP Semiconductors
NXPI
$61.5B
$129M 4.38%
+1,760,765
New +$139M
QRVO icon
11
Qorvo
QRVO
$8.07B
$128M 4.35%
+2,112,943
New +$142M
ISBC
12
DELISTED
Investors Bancorp, Inc.
ISBC
$113M 3.82%
10,833,824
-3,356,227
-24% -$38.7M
W icon
13
Wayfair
W
$11.7B
$110M 3.73%
1,219,464
+326,864
+37% +$34.4M
ZGNX
14
DELISTED
Zogenix, Inc.
ZGNX
$109M 3.69%
2,985,834
-2,320,680
-44% -$95M
ACOR
15
DELISTED
Acorda Therapeutics
ACOR
$85.5M 2.9%
45,759
-13,466
-23% -$29.3M
SRC
16
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$69M 2.34%
1,956,456
-1,782,261
-48% -$68.7M
CNMD icon
17
CONMED
CNMD
$1.32B
$62.2M 2.11%
969,160
-235,691
-20% -$16.1M
PTCT icon
18
PTC Therapeutics
PTCT
$6.21B
$55.8M 1.89%
1,626,965
+9,967
+0.6% +$358K
PRTA icon
19
Prothena Corp
PRTA
$443M
$47.6M 1.61%
4,618,164
+701,757
+18% +$8.34M
AUD
20
DELISTED
Audacy, Inc.
AUD
$33.6M 1.14%
5,888,683
-2,061,968
-26% -$13.7M
YMAB
21
DELISTED
Y-mAbs Therapeutics
YMAB
$31.3M 1.06%
1,587,566
LJPC
22
DELISTED
La Jolla Pharmaceutical Company
LJPC
$22.5M 0.76%
2,387,336
-202,876
-8% -$3.05M
AYI icon
23
Acuity Brands
AYI
$9.99B
$21.4M 0.73%
185,930
THC icon
24
Tenet Healthcare
THC
$22.2B
$14.9M 0.51%
870,695
-985,590
-53% -$23.9M
ICPT
25
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$6.55M 0.22%
64,961

Similar funds

Scopia Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Scopia Capital Management held 40 positions worth $2.95B, down 43% from $5.2B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Scopia Capital Management withdrew a net $1.42B in Q4 2018, closing 12 positions and reducing 14 holdings. Its most notable exit was Forest City Realty Trust, Inc., an estimated $544M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Technology.

Against the trend, Scopia Capital Management opened a new position in Equitrans Midstream Corporation Common Stock worth $142M.

  • Scopia Capital Management's largest Q4 2018 buy was Equitrans Midstream Corporation Common Stock: 7,086,893 shares worth $142M.
  • Scopia Capital Management added most to Wayfair in Q4 2018, an estimated $34.4M increase.
  • Scopia Capital Management's biggest Q4 2018 reduction was Zogenix, Inc., cutting an estimated $95M.
  • Scopia Capital Management fully exited Forest City Realty Trust, Inc. in Q4 2018, selling an estimated $544M.
  • Scopia Capital Management's ten largest holdings make up 69% of its $2.95B portfolio in Q4 2018.
  • Scopia Capital Management opened 3 new positions and closed 12 in Q4 2018.
  • Scopia Capital Management's portfolio value fell 43% quarter-over-quarter to $2.95B.

Based on Scopia Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.